Villaganas, Mark John .

HRN: 23-02-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/27/2025
01/03/2026
PO
8ml
TID
Amebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines